RecallDepth
Class II Ongoing

chlorproMAZINE Hydrochloride Tablets, USP, 10mg, 100-count bottle, RX only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ; Product of India, NDC 68462-861-01

Company
Glenmark Pharmaceuticals Inc., Usa
Recall Initiated
December 11, 2024
Posted
January 1, 2025
Recall Number
D-0159-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
3,888
Firm Location
Mahwah, NJ, United States

Reason for Recall

CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.

Distribution

USA Nationwide

Lot / Code Info

Lot#: 17230132, Exp 12/2024; 17230449, Exp 01/2025

More recalls by Glenmark Pharmaceuticals Inc., Usa

View all recalls by this company →

Other recent Class II Drug recalls